Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium
- 1 April 1988
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 158 (4) , 796-805
- https://doi.org/10.1016/0002-9378(88)90075-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Endometrial carcinoma: Steroid receptors and response to medroxyprogesterone acetateGynecologic Oncology, 1985
- Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1985
- The effect of estrogen receptor status on survival in patients with endometrial cancerAmerican Journal of Obstetrics and Gynecology, 1983
- Cytosol estrogen and progestin receptors in endometrial carcinoma of patients treated with surgery, radiotherapy, and progestin. Clinical correlatesCancer, 1982
- Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: Therapeutic implicationsAmerican Journal of Obstetrics and Gynecology, 1981
- Clinical Correlates of Estrogen- and Progesterone-Binding Proteins in Human Endometrial AdenocarcinomaObstetrics & Gynecology, 1980
- Do Estrogen and Progesterone Receptors (E2R and PR) in Metastasizing Endometrial Cancers Predict the Response to Gestagen Therapy?Acta Obstetricia et Gynecologica Scandinavica, 1980
- Estradiol and progesterone receptors in normal and neoplastic endometrium: Correlations between receptors, histopathological examinations and clinical responses under progestin therapyInternational Journal of Cancer, 1979
- Progesterone binding in human endometrial carcinomasAmerican Journal of Obstetrics and Gynecology, 1976
- Characterization and Properties of Progesterone-Binding Components in Human Endometrium1Journal of Clinical Endocrinology & Metabolism, 1974